A number of studies have documented the successful treatment of ED with MUSE. Padma-Nathan et al 5 reported that 65.9% of men achieved erections sufficient for intercourse after transurethral ...
MOUNTAIN VIEW, Calif., Oct. 4 VIVUS, Inc. (Nasdaq: VVUS) today announced that it has entered into an asset purchase agreement with Meda - an international specialty pharma company - for MUSE®, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results